Blackstone invests $45m in animal drug maker

The investment comes in the form of a subscription of shares and bonds issued by Singapore Exchange-listed China Animal Healthcare.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this